GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 208 filers reported holding GW PHARMACEUTICALS PLC in Q4 2017. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $203,000 | -46.0% | 2,083 | -32.0% | 0.00% | – |
| Q2 2020 | $376,000 | +60.0% | 3,064 | +14.4% | 0.00% | – |
| Q1 2020 | $235,000 | +15.8% | 2,679 | +37.8% | 0.00% | – |
| Q4 2019 | $203,000 | -6.0% | 1,944 | +3.7% | 0.00% | – |
| Q3 2019 | $216,000 | -37.8% | 1,875 | -6.9% | 0.00% | – |
| Q2 2019 | $347,000 | +7.1% | 2,014 | +4.8% | 0.00% | – |
| Q1 2019 | $324,000 | -28.0% | 1,922 | -58.4% | 0.00% | -100.0% |
| Q4 2018 | $450,000 | +278.2% | 4,623 | +439.4% | 0.00% | – |
| Q2 2018 | $119,000 | +1883.3% | 857 | +1847.7% | 0.00% | – |
| Q4 2017 | $6,000 | -88.5% | 44 | -91.4% | 0.00% | – |
| Q3 2017 | $52,000 | -46.4% | 511 | -46.9% | 0.00% | – |
| Q2 2017 | $97,000 | -41.6% | 963 | -30.1% | 0.00% | -100.0% |
| Q1 2017 | $166,000 | +7.8% | 1,378 | +0.1% | 0.00% | 0.0% |
| Q4 2016 | $154,000 | +4.1% | 1,376 | +23.7% | 0.00% | 0.0% |
| Q3 2016 | $148,000 | – | 1,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |